Finding Clinical Trials for CHD: A Guide for Families

HeartWorks Lab technician transferring stem cells to storage.

Families impacted by congenital heart disease (CHD) are often searching for new treatments, therapies, and care options that can improve the lives of their loved ones. One of the most important ways to access cutting-edge care is through clinical research and clinical trials for CHD. At HeartWorks, we are committed to leading and supporting clinical research studies so families can have more options and hope for the future.

In this guide, we break down what clinical research and clinical trials are, how they work, and how CHD families can find opportunities to participate.

What Is Clinical Research for CHD?

Clinical research involves studies with human participants to answer important health questions. For CHD families, this type of research is essential for discovering new therapies, surgical innovations, medications, or devices that can ultimately become part of the standard of care.

Clinical research does not include studies using only existing biological samples or anonymous data. Instead, it focuses on real-time participation to improve health outcomes for children and adults living with congenital heart defects.

Clinical Trials for Congenital Heart Disease

Clinical trials are a specific type of clinical research where participants are assigned to an intervention, such as a new medication, therapy, or medical device, to evaluate how it affects health outcomes. For CHD families, these trials open the door to the latest treatments before they become widely available.

Clinical trials can help answer questions like:

  • Does a new therapy improve heart function or quality of life?
  • Can a new surgical approach reduce recovery time?
  • What new options exist for children and adults after complex surgeries like the Fontan procedure?

At HeartWorks, we proudly serve as the clinical trial sponsor for several CHD studies, guiding their design, funding, and implementation to bring breakthroughs to patients faster.

Observational Studies and Patient Registries

Not all CHD research involves testing new treatments. Observational studies collect information about patients’ health, lifestyle, and outcomes without assigning a specific therapy.

One valuable tool in these studies is a patient registry, a secure database where families can consent to share health information. With registries, researchers can quickly analyze data from hundreds or thousands of CHD patients to uncover patterns, track long-term outcomes, and identify promising future research directions.

The Co-op at HeartWorks is a patient registry built to inform future clinical innovation and design of clinical trials which address the needs of the members.

Where Clinical Trials Take Place: CHD Clinical Trial Site

A clinical trial site is the physical location where research takes place. These can include hospitals, medical centers, or specialized research facilities.

HeartWorks has built an international consortium of leading pediatric CHD care centers across North America and is expanding to include top adult CHD programs as well. By collaborating with these centers, we can make participation in CHD clinical trials more accessible to families.

How CHD Families Can Find Clinical Trials

If you’re a parent or patient looking for clinical trials for congenital heart disease, there are excellent online resources available:

HeartWorks will continue sharing updates about our CHD clinical trials so families can easily find information about new opportunities.

Why Clinical Trials Matter for CHD Families

For children and adults living with CHD, participating in a clinical trial can mean access to the newest treatments, closer monitoring, and the chance to help advance care for future generations. Every study brings the CHD community one step closer to better therapies, better outcomes, and brighter futures.

At HeartWorks, we believe in empowering CHD families with information about clinical research opportunities. Together, we can push the boundaries of what’s possible in CHD care.

Share the Post:

Related Posts

catheter-based cardiac cell delivery technology

One Step Closer: HeartWorks Partners with SmartCella to Advance Cardiac Cell Delivery

Manufacturing personalized cardiac cells is one challenge. Getting them safely into the heart is another. HeartWorks has entered a licensing agreement with SmartCella, a Sweden-based biotech company, for its Extroducer® — a minimally invasive, catheter-based platform that could deliver cardiac cells directly to heart muscle without the need for open-heart surgery. Lab testing showed that our cardiac lineage cells maintained high viability through the delivery process, a key early milestone. Combined with reaching our first 100 biopsy participants, this partnership represents meaningful progress on the path to personalized CHD treatment.

Read More
Lori Riess and Drew Narwold, HeartWorks team members supporting The Co-op patient-driven research platform for congenital heart disease

Lori & Drew: Maximizing the Potential of the Co-op

Behind every patient who joins The Co-op @ HeartWorks, there’s a team making sure the
process is simple, the experience is supportive, and the information shared actually drives
research forward.
Meet two of the people making that happen:
Lori Reiss, Co-op Coordinator, is a personal point of contact for families who want to learn more,
get started, or simply have questions about what participation looks like. Drew Narwold works
behind the scenes to organize and analyze the data participants share — including helping
HeartWorks make smarter decisions about manufacturing personalized cardiac cells for our first
100 participants.
Together, they’re helping close the gap between patient experiences and scientific progress.

Read More

Send A Message

This field is for validation purposes and should be left unchanged.
Name(Required)
Please let us know what's on your mind. Have a question for us? Ask away.